Payment overview · 2025
General Payments
$68.91
2 reported records · 1 companies
Healthcare provider profile · identity verified
Phyllis Andrews
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant · BRONX, NY · NPI 1659590198
Verified facts
What the public records show
CMS Open Payments records show Phyllis Andrews received $68.91 in general payments during 2025 across 2 reported records.
ACADIA Pharmaceuticals Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $68.91 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $68.91 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $68.91 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1722 | 226 |
| Amlodipine Besylate | Amlodipine Besylate | 1383 | 181 |
| Tamsulosin Hcl | Tamsulosin Hcl | 894 | 115 |
| Metformin Hcl | Metformin Hcl | 705 | 87 |
| Gabapentin | Gabapentin | 677 | 93 |
| Eliquis | Apixaban | 555 | 74 |
| Losartan Potassium | Losartan Potassium | 554 | 71 |
| Metoprolol Succinate | Metoprolol Succinate | 444 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 433 | 53 |
| Lisinopril | Lisinopril | 425 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 409 | 62 |
| Metoprolol Tartrate | Metoprolol Tartrate | 402 | 54 |
| Furosemide | Furosemide | 392 | 68 |
| Clopidogrel | Clopidogrel Bisulfate | 358 | 46 |
| Famotidine | Famotidine | 323 | 52 |
| Finasteride | Finasteride | 302 | 38 |
| Nifedipine Er | Nifedipine | 298 | 39 |
| Simvastatin | Simvastatin | 286 | 32 |
| Omeprazole | Omeprazole | 280 | 43 |
| Carvedilol | Carvedilol | 245 | 31 |
| Jardiance | Empagliflozin | 241 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 232 | 33 |
| Levetiracetam | Levetiracetam | 217 | 32 |
| Pantoprazole Sodium | Pantoprazole Sodium | 210 | 35 |
| Ammonium Lactate | Ammonium Lactate | 194 | 49 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 161 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 146 | 26 |
| Trulicity | Dulaglutide | 143 | 21 |
| Entresto | Sacubitril/Valsartan | 128 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 118 | 33 |
| Januvia | Sitagliptin Phosphate | 118 | 20 |
| Baclofen | Baclofen | 117 | 15 |
| Montelukast Sodium | Montelukast Sodium | 113 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 111 | 30 |
| Spironolactone | Spironolactone | 104 | 17 |
| Enalapril Maleate | Enalapril Maleate | 97 | 13 |
| Farxiga | Dapagliflozin Propanediol | 97 | 18 |
| Mirtazapine | Mirtazapine | 97 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 96 | 11 |
| Donepezil Hcl | Donepezil Hcl | 91 | 11 |
| Mupirocin | Mupirocin | 91 | 48 |
| Xarelto | Rivaroxaban | 91 | 12 |
| Meclizine Hcl | Meclizine Hcl | 87 | 14 |
| Trazodone Hcl | Trazodone Hcl | 87 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 84 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 82 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 82 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 81 | 11 |
| Sertraline Hcl | Sertraline Hcl | 76 | suppressed |
| Memantine Hcl | Memantine Hcl | 72 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 71 | suppressed |
| Atenolol | Atenolol | 70 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 70 | 19 |
| Allopurinol | Allopurinol | 68 | 12 |
| Glipizide | Glipizide | 68 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 68 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 67 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | suppressed |
| Ketoconazole | Ketoconazole | 60 | 11 |
| Latanoprost | Latanoprost | 60 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 59 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | 13 |
| Ezetimibe | Ezetimibe | 57 | suppressed |
| Meloxicam | Meloxicam | 57 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 56 | 11 |
| Lactulose | Lactulose | 56 | 13 |
| Ozempic | Semaglutide | 56 | suppressed |
| Novolog | Insulin Aspart | 54 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 52 | suppressed |
| Hydrocortisone | Hydrocortisone | 51 | 30 |
| Lidocaine | Lidocaine | 49 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 48 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 48 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 47 | suppressed |
| Azithromycin | Azithromycin | 45 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 45 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 43 | suppressed |
| Potassium Chloride | Potassium Chloride | 43 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 41 | 17 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 40 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 39 | suppressed |
| Folic Acid | Folic Acid | 39 | suppressed |
| Nystatin | Nystatin | 39 | 12 |
| Vascepa | Icosapent Ethyl | 39 | suppressed |
| Pregabalin | Pregabalin | 38 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 37 | suppressed |
| Tradjenta | Linagliptin | 37 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 36 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 35 | suppressed |
| Bumetanide | Bumetanide | 33 | suppressed |
| Dulera | Mometasone/Formoterol | 33 | suppressed |
| Prednisone | Prednisone | 33 | 19 |
| Aripiprazole | Aripiprazole | 32 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 32 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 31 | suppressed |
| Amantadine | Amantadine Hcl | 30 | suppressed |
| Creon | Lipase/Protease/Amylase | 30 | suppressed |
| Glipizide Er | Glipizide | 30 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 30 | suppressed |
| Novolin R | Insulin Regular, Human | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Colchicine | Colchicine | 28 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 28 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 28 | 11 |
| Cilostazol | Cilostazol | 27 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Humalog | Insulin Lispro | 25 | suppressed |
| Loperamide | Loperamide Hcl | 25 | 15 |
| Oxcarbazepine | Oxcarbazepine | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Calcium Acetate | Calcium Acetate | 24 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 24 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Clotrimazole | Clotrimazole | 22 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 22 | suppressed |
| Insulin Aspart | Insulin Aspart | 22 | 14 |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 21 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 21 | 14 |
| Sevelamer Carbonate | Sevelamer Carbonate | 21 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 21 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 20 | suppressed |
| Levemir | Insulin Detemir | 19 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 18 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Ibuprofen | Ibuprofen | 17 | 14 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Lacosamide | Lacosamide | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 15 | suppressed |
| Acetazolamide | Acetazolamide | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Insulin Lispro | Insulin Lispro | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Admelog Solostar | Insulin Lispro | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Cephalexin | Cephalexin | 12 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | 11 |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 12 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Repaglinide | Repaglinide | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 11 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $68.91 · 2 records | ACADIA Pharmaceuticals Inc | NUPLAZID | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error